UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000016458
Receipt No. R000019117
Official scientific title of the study Safety and efficacy of rotavirus vaccine in infants admitting NICU; comparison between RV1 and RV5.
Date of disclosure of the study information 2015/02/06
Last modified on 2019/02/05 (Ver. 5)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Safety and efficacy of rotavirus vaccine in infants admitting NICU; comparison between RV1 and RV5.
Title of the study (Brief title) Safety and efficacy of rotavirus vaccine in infants admitting NICU.
Region
Japan

Condition
Condition Infants in NICU
Classification by specialty
Pediatrics
Classification by malignancy Others
Genomic information YES

Objectives
Narrative objectives1 To elucidate safety and efficacy of rotavirus vaccine in infants admitting NICU.
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Spreading of rotavirus vaccine strains in NICU.
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Active
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 2
Purpose of intervention Prevention
Type of intervention
Vaccine
Interventions/Control_1 RV1 rotavirus vaccine
Interventions/Control_2 RV5 rotavirus vaccine
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit

Not applicable
Age-upper limit
32 weeks-old >=
Gender Male and Female
Key inclusion criteria Infants in NICU that meet to the requirements for rotavirus vaccine.
Key exclusion criteria Underlying diseases associated with gastrointestinal disease.
Target sample size 40

Research contact person
Name of lead principal investigator Tetsushi Yoshikawa
Organization Fujita Health University School of Medicine
Division name Dept. of Pediatrics
Address 1-98, Dengakugakubo, Kutsukake-cho, Toyoake, Aichi.Japan
TEL +81-562-93-9251
Email tetsushi@fujita-hu.ac.jp

Public contact
Name of contact person Tetsushi Yoshikawa
Organization Fujita Health University School of Medicine
Division name Dept. of Pediatrics
Address 1-98, Dengakugakubo, Kutsukake-cho, Toyoake, Aichi.Japan
TEL +81-562-93-9251
Homepage URL
Email tetsushi@fujita-hu.ac.jp

Sponsor
Institute Fujita Health University School of Medicine. Dept. of Pediatrics
Institute
Department

Funding Source
Organization Health Labour Sciences Research Grant
Organization
Division
Category of Funding Organization Japanese Governmental office
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2015 Year 02 Month 06 Day

Progress
Recruitment status Completed
Date of protocol fixation
2014 Year 05 Month 01 Day
Anticipated trial start date
2015 Year 02 Month 06 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Published
URL releasing results
Results
Other related information

Management information
Registered date
2015 Year 02 Month 06 Day
Last modified on
2019 Year 02 Month 05 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000019117